Azienda Socio Sanitaria Territoriale Dei Sette Laghi — Clinical Trial Site

71 Registered trials

38 Currently recruiting

Organisation

Azienda Socio Sanitaria Territoriale Dei Sette Laghi

Location

Varese, Italy

Identifier

ORG-100043719

Address

Viale Luigi Borri N 57, 21100, Italy

Departments

#2832: Struttura Complessa Medicina Genarale
Anestesia e Terapia intesiva
AO Ospedale di Circolo e Fondazione Macchi
ASSL Sette Laghi - Ospedale Tradate
Complex Structure of Hematology
Department of Emergency and Thrombosis and Hemostasis clinic
Dipar&mento di Ematologia
Dipartimento di Emergenza e Urgenza
DIPARTIMENTO DI MEDICINA SPECIALISTICA
Dipartimento Emergenza
dipartimento ginecologia e ostreticia
Dipartimento Materno Infantile
Division of Hematology
DIVISIONE DI EMATOLOGIA
Ematologia
Endocrinology
General Medicine
Ginecology
Haematology Department
Hematology
IT052A: Unità Operativa Complessa di Ematologia
Medical Area Department
Medical oncology
Medicina Interna
N/A
ONCOEMATOLOGIA
Oncologia
Oncologia Medica
Oncology
Ospedale di Circolo e Fondazione Macchi -SC Ematologia
Ospedale di Circolo e Fondazione Macchi, SC Ematologia
Ospedale Galmarini di Tradate
Pediatria
Pediatria Ospedale Filippo del Ponte
Presidio Ospedale di Circolo e Fondazione Macchi - Oncologia Medica
S.C. EMATOLOGIA
S.C. Gastroenterology and Digestive Endoscopy
S.C. Oncologia
S.C. Oncologia Medica
S.C. Pediatrics, Pediatric Auxology, Endocrinology and Diabetology Clinic
SC di Ematologia
SC Ematologia
SC Endocrinologia, Ospedale di Circolo e Fondazione Macchi, Viale Borri 57, 21100 Varese
SC Medicina Generale
SC Oncologia
SC Oncologia Medica
Struttura Complessa Nefrologia e Dialisi
U.O. di Oncologia Medica
U.O.C Ematologia
Unità di Medicina e Patologia Orale SC Odontostomatologia
UOC Ematologia

Clinical trials at this site (71)

Search interface

Phase III Trial of Volrustomig (MEDI5752) in Combination with Carboplatin plus Pemetrexed vs. Investigator’s Choice of the Standard of Care … Ended

2023-503231-17-00 Unresectable Pleural Mesothelioma 5 2024-04-26
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
A Phase 3 Randomized Study Comparing Teclistamab Monotherapy versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethas… Ended

2023-503444-13-00 Relapsed/refractory multiple myeloma 5 2023-03-29
Phase 3 Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGF… Ended

2023-507964-38-00 Metastatic or Locally Advanced Epidermal Growth Factor 5 2022-09-01
A study to evaluate KER-050 as a monotherapy or in combination with Ruxolitinib in Myelofibrosis. Ended

2023-507468-38-00 Myelofibrosis 4 2022-04-22
Study aimed at evaluating the efficacy of a combination treatment (decitabine and venetoclax) in patients with Acute Myeliode Leukemia who a… Ended

2023-510241-16-00 Acute Myeloid Leukemia secondary to myeloproliferative 4 2021-12-03
The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and… Ended

2023-508968-30-00 Adult Philadelphia Chromosome-Positive Acute Lymphoblas 5 2021-09-08
PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controll… Ended

2024-511321-54-00 intermediate-high-risk acute pulmonary embolism 5 2021-08-04
A clinical study to assess the effectiveness and safety of LOXO-305 compared to standard of care treatment chosen by the Investigator in pat… Ended

2023-507695-52-00 Mantle cell lymphoma 5 2021-03-05
A Phase 3 Trial of Epcoritamab vs Investigator’s Choice Chemotherapy in R/R DLBCL Ended

2023-504830-23-00 B-cell Lymphoma 5 2020-12-16
PACIFICA: A Phase 3 Study of Pacritinib in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thro… Ended

2024-515953-52-00 Post-Essential Thrombocythaemia Myelofibrosis 5 2020-07-24
Therapy with ibrutinib for patients with Chronic lymphocytic leukemia with subclonal TP53 aberrations Ended

2024-514823-41-00 Chronic Lymphocytic Leukemia (CLL) 4 2019-04-29
Clinical trial with Ibrutinib and Venetoclax for patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Ended

2024-514686-19-00 Relapsed or Refractory Chronic Lymphocytic Leukemia 4 2017-03-10
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A study of efgartigimod PH20 SC given by prefilled syringe in adults with thyroid eye disease Ended

2023-509197-35-00 Thyroid Eye Disease (TED) 5 2024-10-17
Open-label study to evaluate metreleptin in children under 6 years of age with generalised lipodystrophy Ended

2022-501781-22-00 Generalised lipodystrophy 5 2024-02-09
A study to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis Ended

2023-503315-15-00 Thrombolysis of symptomatic proximal vein thrombosis 4 2023-12-20
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed S… Ended

2024-513559-34-00 Small Cell Lung Cancer (SCLC) 5 2022-07-19
N/A Ended

2024-515090-96-00 Thyroid Eye Disease 11 2022-05-10
A clinical study to compare the safety, effectiveness and pharmacokinetics (the way the body absorbs, distributes, and gets rid of a drug) o… Ended

2023-507143-11-00 Precancerous form of blood cancer in the bone marrow 5 2017-11-08
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab (A-Brave) Ended

2024-514515-10-00 Breast Cancer 5 2016-06-16
THIS IS A CLINICAL STUDY WHICH EVALUATES TREATMENT WITH CHLORAMBUCIL AND RITUXIMAB FOLLOWED BY RITUXIMAB GIVEN UNDER THE SKIN IN PATIENTS W… Ended

2023-507291-52-00 Extranodal Marginal Zone Lymphoma 4 2014-03-24